Den europeiske union - engelsk - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv infections - antivirals for systemic use - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.

Israel - engelsk - Ministry of Health

glaxo smith kline (israel) ltd - abacavir as sulfate; dolutegravir as sodium; lamivudine - film coated tablets - dolutegravir as sodium 50 mg; abacavir as sulfate 600 mg; lamivudine 300 mg - lamivudine and abacavir and dolutegravir - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults and adolescents above 12 years of age weighing at least 40 kg.before initiating treatment with abacavir-containing products, screening for carriage of the hla-b*5701 allele should be performed in any hiv-infected patient, irrespective of racial origin. abacavir should not be used in patients known to carry the hla-b*5701 allele.

Canada - fransk - Health Canada

viiv healthcare ulc - dolutÉgravir (dolutegravir sodium); abacavir (sulfate d'abacavir); lamivudine - comprimé - 50mg; 600mg; 300mg - dolutÉgravir (dolutegravir sodium) 50mg; abacavir (sulfate d'abacavir) 600mg; lamivudine 300mg - hiv integrase inhibitors

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - abacavir sulfate, quantity: 702 mg (equivalent: abacavir, qty 600 mg); lamivudine, quantity: 300 mg; dolutegravir, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; povidone; magnesium stearate; purified water; mannitol; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - trelavue is indicated for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age who are antiretroviral treatment-na?ve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents (dolutegravir, abacavir or lamivudine) in trelavue.

Tanzania - engelsk - Tanzania Medicinces & Medical Devices Authority

emcure pharmaceutical limited., india - dolutegravir sodium, lamivudine , tenofovovir disoproxil fumarate - tablets - dolutegravir 50mg/lamivudinr 300mg/tenofovir 300 mg

Tanzania - engelsk - Tanzania Medicinces & Medical Devices Authority

emcure pharmaceutical limited., india - dolutegravir sodium, lamivudine , tenofovovir disoproxil fumarate - tablets - dolutegravir 50mg/lamivudinr 300mg/tenofovir 300 mg

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

camber laboratories sdn. bhd. - lamivudine; tenofovir disoproxil fumarate; dolutegravir sodium -

Kenya - engelsk - Pharmacy and Poisons Board

dolutegravir sodium. - tablet - : each film coated tablet contains: dolutegravir… - dolutegravir

Den europeiske union - bulgarsk - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - ХИВ инфекции - Антивирусни средства за системно приложение - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.

Brasil - portugisisk - ANVISA (Agência Nacional de Vigilância Sanitária)

fundaÇÃo oswaldo cruz - dolutegravir sódico - antiretroviral